Skip to main content
. 2017 Feb 3;12(2):e0171545. doi: 10.1371/journal.pone.0171545

Table 1. Baseline characteristics.

Clinical profile Total (n = 7775) Incident AF (n = 367) No AF (n = 7408) P-value
Telomere length 0.00 (-0.18–0.20) -0.03 (-0.21–0.13) 0.00 (-0.18–0.21) 0.013
Age-years 49±13 62±9 48±12 <0.001
Male sex 3872 (50%) 254 (69%) 3618 (49%) <0.001
BMI-kg/m2 25.6 (23.1–28.4) 27.5 (25.2–29.9) 25.5 (23.1–28.3) <0.001
Obesity 1210 (16%) 90 (25%) 1120 (15%) <0.001
Systolic blood pressure-mmHg 129±20 143±22 128±20 <0.001
Diastolic blood pressure-mmHg 74±10 79±9 74±10 <0.001
Heart rate-bpm 69±10 67±10 69±10 <0.001
Hypertension 2093 (27%) 198(54%) 1895 (26%) <0.001
Heart failure 17 (0.2%) 6 (1.6%) 11 (0.1%) 0.002
Diabetes mellitus 285 (4%) 35 (10%) 250 (3%) <0.001
Smoking 3442 (45%) 143 (39%) 3299 (45%) 0.040
Hypercholesterolemia 333 (4%) 42 (12%) 291 (4%) <0.001
Glucose lowering treatment 107 (2%) 11 (3%) 96 (2%) 0.020
Lipid lowering treatment 314 (5%) 41 (13%) 273 (4%) <0.001
Myocardial infarction 228 (3%) 50 (14%) 178 (2%) <0.001
Stroke 54 (0.7%) 8 (2.2%) 46 (0.6%) 0.003
Antihypertensive treatment 1036 (16%) 131 (41%) 905 (15%) <0.001
PR-interval-ms 158 (143–172) 168 (153–187) 158 (143–172) <0.001
Biomarker profile Total (n = 7775) Incident AF (n = 367) No AF (n = 7408) P-value
eGFR-ml/min/1.73m2 80.9±14.5 76.6±15.7 81.1±14.4 <0.001
Creatinine-umol/L 82.0 (73.0–92.0) 88.0 (77.0–98.0) 82.0 (73.0–91.0) <0.001
NTpro-BNP-ng/L 37.3 (16.6–72.6) 86.3 (40.8–195.5) 35.7 (16.0–69.0) <0.001
hs-CRP -mg/L 1.27 (0.55–2.94) 1.97 (0.94–3.66) 1.25 (0.54–2.89) <0.001
Glucose-mmol/L 4.9±1.2 5.4±1.7 4.9±1.2 <0.001

Data is expressed as mean ± standard deviation, median (interquartile range) or numbers (%). Telomere lengths are divided in quartiles. Abbreviations: AF = atrial fibrillation, BMI = body mass index, eGFR = estimate glomerular filtration rate, hs-CRP = highly sensitive C-reactive protein, NT pro-BNP = N-terminal prohormone of brain natriuretic peptide.